Injective
Why Injective is down 4.6% today
Analysis
Injective (INJ) fell 4.6% over the past 24 hours as sentiment likely softened following comments from Injective’s CEO highlighting a “tug-of-war” among Layer-1 chains between scaling for adoption and maintaining decentralization. The discussion may have raised near-term concerns about trade-offs in L1 design and governance, weighing on INJ despite no concrete protocol change being announced.
Contributing Factors (1)
L1s face decentralization 'tug-of-war' as adoption grows: Injective CEO
Blockchains will face increasing pressure to compromise on decentralization to meet user demand for speed and scalability, Injective CEO Eric Chen said.
Move Details
Explanation Confidence
Moderate confidence. Multiple factors may be contributing.